In the current month, USNA has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. USNA average Analyst price target in the last month is 25.000.
Based on analysts' estimates, USNA EPS is projected to reach 0.110 in FY2026Q4, following reported EPS of -0.300 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.30, while USANA Health Sciences IncUSNA's earnings per share (EPS) for the previous quarter was USD -1.16. EPS for the next quarter is expected at USD 0.11.